HematologyNews.net

Hematology Xagena

Search results for "Arzerra"

The study enrolled patients with chronic lymphocytic leukemia ( CLL ), heavily pre-treated, who did not respond to, or who were ineligible for, currently available treatment options such as Fludarabin ...


According to NICE ( National Institute for Health and Clinical Excellence ) Ofatumumab ( Arzerra ) is not recommended for the treatment of chronic lymphocytic leukaemia that is refractory to Fludarabi ...


GlaxoSmithKline ( GSK ) and Genmab have announced the results from the concluded pivotal trial of Ofatumumab ( Arzerra ) in patients with Fludarabine ( Fludara ) and Alemtuzumab ( Campath ) refractory ...


Ofatumumab ( Arzerra ) is a fully human monoclonal antibody that binds to both the large and small extracellular loops of CD20. Ofatumumab is currently approved for patients with refractory chronic ly ...


The FDA ( Food and Drug Administration ) has approved a Supplemental Biologic License Application ( sBLA ) for the use of Arzerra ( Ofatumumab ), a CD20-directed cytolytic monoclonal antibody, in comb ...


Patients with chronic lymphoid leukemia ( CLL ) or small lymphocytic lymphoma ( SLL ) who experience short response duration or adverse cytogenetics have poor outcomes. Researchers have evaluated th ...